-
Propidium Iodide for Viability and Cell-Cycle Assays
2026-09-18
Propidium iodide converts membrane damage and DNA content into measurable red fluorescence for cell viability assay, apoptosis detection, and cell cycle analysis. This guide shows how to adapt PI workflows to evaluate cellular responses to processed lactoferrin while separating membrane integrity from broader claims about protein structure or bioactivity.
-
Miltefosine: From PI3K/Akt to Neutrophil Recovery
2026-09-18
Miltefosine is emerging as a context-dependent signaling modulator with established PI3K/Akt research applications and a new translational rationale in neutrophil differentiation. This article examines the evidence, experimental priorities, competitive landscape, and safeguards needed to evaluate its potential in leukopenia research.
-
Cholesterol Workflows for mRNA-LNP Research
2026-09-17
Use Cholesterol as a defined membrane-engineering input for lipid nanoparticle formulation, membrane fluidity assay design, and lipid metabolism research. This practical guide connects controlled sterol handling with localized p21 mRNA-LNP studies while separating evidence-backed findings from workflow recommendations.
-
CA-074 Me: Reading Cathepsin B in Cell Death
2026-09-17
CA-074 Me is a membrane-permeable cathepsin B inhibitor that can help distinguish lysosomal protease activity from the upstream event of lysosomal membrane permeabilization. This article translates recent MLKL–lysosome findings into a causality-focused design for apoptosis assays, necroptosis studies, and inflammation research.
-
Live-Dead Cell Staining Kit I: Ferroptosis Readouts
2026-09-16
Learn how the Live-Dead Cell Staining Kit I converts membrane integrity into an interpretable ferroptosis endpoint in mammalian cells. This guide connects Calcein AM/PI staining with gramine-induced TNBC research while emphasizing controls, timing, and orthogonal validation.
-
Calcein AM/PI for Translational Cell Viability
2026-09-16
A mechanistic and strategic guide to using the Live-Dead Cell Staining Kit I (Calcein AM/PI) as a foundational readout in biomaterial, bone regeneration, and mammalian cell viability research.
-
miR-519d-3p Exosomes and Preeclampsia
2026-09-15
The reference study links elevated miR-519d-3p in placenta-derived exosomes with altered T-cell behavior relevant to preeclampsia. Its integrated sequencing and cell-based approach suggests that exosomal miRNA cargo may contribute to immune intolerance by increasing Jurkat T-cell proliferation, suppressing apoptosis, and shifting differentiation toward Th17 cells.
-
Annexin V Workflow for Apoptosis Assays
2026-09-15
Learn how to use Annexin V, human recombinant as a flexible phosphatidylserine probe for early apoptosis, custom labeling, and cell-surface binding studies. This workflow combines practical assay parameters with reference-backed guidance for separating phosphatidylserine detection from coagulation-related functional experiments.
-
Mitochondrial TERC-53 Signaling in Senescence
2026-09-14
The reference study identifies mitochondrion-processed TERC-53 as a non-coding RNA signal that links mitochondrial status to cellular senescence and age-related cognitive decline without changing telomerase activity. Its experimental design separates TERC-53 signaling from canonical telomere maintenance, offering a useful framework for studying specific mitochondrial retrograde pathways.
-
DAPT (GSI-IX): Mechanism, Evidence, and Use
2026-09-14
DAPT, also called GSI-IX, is a selective γ-secretase inhibitor used to perturb amyloid precursor protein and Notch receptor processing. Its reported cellular IC50 values are assay-dependent, so DAPT is best interpreted as a mechanistic research tool rather than a standalone therapeutic proxy.
-
JZL184 Workflow for Endocannabinoid Pain Research
2026-09-13
JZL184 provides a direct way to test how MAGL-dependent 2-AG turnover shapes synaptic plasticity, inflammatory pain, and pain-related affect. This workflow connects target engagement measurements with behavioral, electrophysiological, lipidomic, and circuit-level readouts inspired by a recent cannabidiol pain study.
-
Recombinant Annexin V Maps Cardiomyocyte Death After I/R
2026-09-12
The reference study established labeled human recombinant Annexin V as an in vivo method for visualizing phosphatidylserine exposure during early cardiomyocyte death after myocardial ischemia and reperfusion. Its time-resolved measurements also showed that Annexin V can evaluate cell death–blocking interventions before DNA fragmentation becomes the sole readout.
-
Live-Dead Cell Staining Kit I: Applied Workflow
2026-09-11
Build a quantitative mammalian cell viability assay around Calcein AM for viable-cell esterase activity and PI for membrane compromise. This workflow translates insights from cerium oxide nanoparticle root-canal research into practical cytocompatibility, biomaterial, and cell cytotoxicity testing while preserving the critical distinction between mammalian-cell readouts and bacterial disinfection assays.
-
Caspase-3 Fluorometric Assay Kit: DEVD Readout
2026-09-11
The Caspase-3 Fluorometric Assay Kit provides a rapid biochemical readout of DEVD-dependent caspase-3 activity through fluorogenic DEVD-AFC cleavage. It supports quantitative comparison of apoptotic and control lysates, but the signal should be interpreted as a protease-activity measurement rather than standalone proof of apoptosis.
-
CGF, ROS, and Metabolic Reprogramming in Colorectal Cancer
2026-09-10
A 2026 iScience study identifies Cya-Gly-Fer (CGF), a natural anthocyanin derivative, as an inhibitor of colorectal cancer growth and metastasis through ROS-driven metabolic and mitochondrial stress. Its integrated cell, organoid, xenograft, transcriptomic, and metabolomic design connects ABC transporter disruption with ATP accumulation, MAPK/ERK1/2/c-MYC suppression, cell-cycle arrest, and apoptosis.